Compare Datadog Inc (DDOG) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Datadog Inc vs Zoetis Inc — how do they compare? Datadog Inc trades at $293.26 (market cap $98.31B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Datadog Inc is far larger — about 3.3× Zoetis Inc's market cap, and Zoetis Inc pays a 2.9% dividend while Datadog Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Datadog Inc for 76 Days and Zoetis Inc for 70 Days on average.
| DDOG | ZTS | |
|---|---|---|
Market Cap | $98.31B | $30.20B |
Volume | 2,936,660 | 6,175,327 |
Sector | Technology | Health |
52-Week High | $288.15 | $147.53 |
52-Week Low | $102.62 | $69.09 |
Typical Hold Time | 76 Days | 70 Days |
Enterprise Value | $94.61B | $37.76B |
Dividend Yield | — | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Datadog (DDOG) trades at $273.80, up 0.91% today, and is approaching its consensus price target of $276.10. The stock exhibits a bullish technical trend, supported by strong moving averages, while recent earnings have consistently beaten expectations. Revenue growth remains robust, projected to reach $4.0 billion in 2026, though net margins are volatile. Positive analyst sentiment, with 83% buy ratings, reflects confidence in the company's AI and enterprise expansion.
The outlook for DDOG is favorable given accelerating AI adoption and international growth, but high valuation multiples (P/E 547.6) pose a risk if growth slows. Investor sentiment is buoyed by strategic positioning in cloud observability, yet competition and customer spending pressures remain key watchpoints for sustained upside.
Zoetis (ZTS) trades at $73.08, up 2.14% today, with a bullish technical signal but mixed earnings history including a recent Q1 2026 miss. The stock shows strong profitability with a 27.69% net income margin and 64.91% ROE, while valuation metrics like a P/E of 11.92 appear reasonable. Recent news highlights competitive pressures in the U.S. pet care market, though international segments remain resilient.
The outlook is cautiously optimistic; ZTS faces near-term headwinds from weak U.S. demand and competition, but its industry-leading margins and dominant market position support long-term growth. Risks include pricing erosion and guidance cuts, yet the consensus price target of $87.33 suggests upside potential for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Datadog Inc
Datadog is a cloud-native company that focuses on analyzing machine data. The firm's product portfolio, delivered as software-as-a-service, allows a client to monitor and analyze its entire IT infrastructure. Datadog's platform can ingest and analyze large amounts of machine-generated data in real time, allowing clients to utilize it for a variety of different applications throughout their businesses.
Read more on DDOG →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
